Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Paclitaxel and its derivativesF1 I SEP / 98
Palbociclib or its saltsPDL I AUG / 16
PaliferminF1 I FEB / 07
Paliperidone and its salts and its derivativesF1 I MAY / 09
PalivizumabF1 I MAY / 04
Pamidronic acid and its saltsF1 I SEP / 98
Pancreatic extractsPDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancreatic extracts, pancreatin, pancrelipase except when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency U DEC / 13
PancreatinPDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
PancrelipasePDL

when sold in a dosage form that provides more than 20 000 USP units of lipase activity per dosage unit or indicated for the treatment of pancreatic exocrine insufficiency

I DEC / 13
Pancuronium and its saltsF1 I SEP / 98
PanitumumabF1 I OCT / 09
Pantoprazole and its saltsF1 I SEP / 98
Papain as a debriding agent U SEP / 99
Papaveretrine and its salts I SEP / 98
Papaverine and its salts I SEP / 98
ParaldehydeF1 I SEP / 98
ParamethadioneF1 I SEP / 98
Pargyline and its saltsF1 I SEP / 98
ParicalcitolF1 I FEB / 07
Paritaprevir (Veruprevir)PDL I MAR / 15
ParomomycinF1 I SEP / 98
Paroxetine and its saltsF1 I SEP / 98
Paroxypropione II SEP / 98
Pazopanib or its saltsPDL I DEC / 13
Pegaptanib and its saltsF1 I FEB / 07
PegaspargasePDL I APR / 17
PegfilgrastimF1 I APR / 07
PegvisomantF1 I FEB / 07
PembrolizumabPDL I JUN / 15
Pemetrexed and its saltsF1 I APR / 07
Pemoline and any salts thereofC4 I JAN / 03
Penciclovir and its saltsF1 I MAY / 00
PenicillamineF1 I SEP / 98
Penicillin or its salts or derivativesPDL

including but not limited to amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, nafcillin, oxacillin and ticarcillin

I DEC / 13
Pentaerythritol tetranitrate I SEP / 98
Pentagastrin and its salts II SEP / 98
Pentamidine and its saltsF1 I SEP / 98
PentazocineN I JUN / 02
PentobarbitalC1 I JUN / 02
Pentolinium tartrateF1 I SEP / 98
Pentosan polysulfate and its saltsF1 I SEP / 98
Pentostatin and its saltsF1 I SEP / 98
Pentoxifylline and its saltsF1 I SEP / 98
Pepsin U
Peptone U
Peramivir or its salts or derivativesPDL I APR / 17
PerflutrenF1 I JUL / 03
Pergolide and its saltsF1 I SEP / 98
Pericyazine and its saltsF1 I SEP / 98
Perindopril and its saltsF1 I SEP / 98
Permethrin and its derivatives II SEP / 98
Perphenazine and its saltsF1 I SEP / 98
Pertussis vaccine II DEC / 98
PethidineN I JUN / 02
Pethidine Intermediate CN I JUN / 02
Phacetoperane and its saltsF1 I SEP / 98
PhenacemideF1 I SEP / 98
PhenacetinF1 I SEP / 98
PhenadoxoneN I JUN / 02
PhenaglycodolF1 I SEP / 98
PhenampromideN I JUN / 02
PhenazocineN I JUN / 02
Phenazopyridine and its saltsF1 I SEP / 98
PhencyclidineN I JUN / 02
Phendimetrazine and any salt thereofC1 I JUN / 02
Phenelzine and its saltsF1 I SEP / 98
Phenformin and its saltsF1 I SEP / 98
Pheniprazine and its saltsF1 I SEP / 98
Pheniramine U
Phenmetrazine and any salt thereofC1 I JUN / 02
PhenobarbitalC2 I JUN / 02
Phenol preparations with concentration of more than 20% II SEP / 98
PhenomorphanN I JUN / 02
PhenoperidineN I JUN / 02
Phenoxybenzamine and its salts II SEP / 98
Phentermine and any salt thereofC2 I JUN / 02
Phenthoxate and its saltsF1 I SEP / 98
Phentolamine or its saltsPDL I DEC / 13
Phenylbutazone and its saltsF1 I SEP / 98
Phenylbutyrate sodiumPDL I MAR / 15
Phenylephrine and its saltsF1 in preparations for parenteral use or ophthalmic use in concentrations greater than 2.5% I SEP / 98
Phenylephrine and its salts and preparations in nasal preparations in concentrations of 2.5% or less, for pediatric use II SEP / 98
Phenylephrine and its salts and preparations. for oral use, in nasal preparations for adults and in ophthalmic preparations in concentrations of 2.5% or less U
Phenylindanedione and its derivativesF1 I SEP / 98
Phenylmethylbarbituric AcidC2 I JUN / 02
Phenyltoloxamine and its salts III SEP / 98
PholcodineN I JUN / 02
Physostigmine salicylateF2 except preparations for oral or topical use only I SEP / 98
Physostigmine salicylate.

for oral or topical use

II SEP / 98
PibrentasvirPDL I SEP / 17
Pilocarpine and its saltsF1 I SEP / 98
PimecrolimusF1 I JUN / 06
PiminodineN I JUN / 02
PimobendanF1 I JUN / 08
PimozideF1 I SEP / 98
Pinaverium bromideF1 I SEP / 98
PinazepamTS I JUN / 02
Pindolol and its saltsF1 I SEP / 98
Pioglitazone and its salts.F1 I OCT / 03

206 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled